Agreements Boost Fiscal 2025 Revenue and Expand Datasea’s 5G Application Market Positioning in China BEIJING, Sept. 17, 2024 /PRNewswire/ — Datasea Inc. (NASDAQ: DTSS) (“Datasea” or the “Company”), a Nevada-based company focused on innovative high-tech acoustics and 5G-Artificial Intelligence (“AI”) multimodal digital technology in the United States and China, today announced that, on August 12,…

Ainos Plans to Conduct Study at National Taiwan University Hospital for HIV-Related Oral Warts Treatment Introduction Ainos, Inc. is set to initiate a clinical study at the prestigious National Taiwan University Hospital for the treatment of Human Immunodeficiency Virus (HIV)-related oral warts. The study will focus on evaluating the efficacy of VELDONA®, a low-dose oral…

Lululemon Athletica Inc. Investment Losses and Potential Recovery Introduction Recently, if you have experienced a loss on your investment in Lululemon Athletica Inc. (NASDAQ:LULU), you may be eligible for a potential recovery under the federal securities laws. It is essential to understand your rights and options during this challenging time. For more information on how…

Seeking Recovery for Extreme Networks, Inc. Investors An Opportunity for Justice As an investor, it can be devastating to suffer a loss on your investment. Extreme Networks, Inc. (NASDAQ:EXTR) shareholders who find themselves in this situation may have a chance at recovery under the federal securities laws. If you are looking to explore your options…

Politan Capital Management Issues Open Letter to Masimo Corporation Shareholders New York, NY – Politan Capital Management, a major shareholder of Masimo Corporation, has released a letter to shareholders urging support for its nominees at the upcoming Annual Meeting of Stockholders. Dear Fellow Masimo Shareholders, Politan Capital Management, together with its affiliates, has recently announced…

Pharma-Bio Serv Announces Decrease in Revenues for 2024 Overview Pharma-Bio Serv, Inc. recently announced a decrease in revenues for the three and nine months ended July 31, 2024. The company reported revenues of approximately $2.4 million and $7.2 million for the respective periods, marking a significant decrease compared to the same periods last year. Financial…

Exciting News in the Biomedical Industry! NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) — DSS, Inc. (NYSE American: DSS), a dedicated supporter and investor in Impact BioMedical Inc. (NYSE American: IBO), is delighted to announce the successful pricing of Impact BioMedical’s initial public offering (IPO). Impact BioMedical, a trailblazer in advancing human healthcare and wellness…